Article
Late Relapse after a Sustained Virologic Response at 24 Weeks after Treatment with Daclatasvir and Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b Infection with Liver Cirrhosis.
Internal medicine (Tokyo, Japan) - 1 Apr 2018
Uojima Haruki, Murakami Shuko, Nakatani Seigo, Hidaka Hisashi, Takeuchi Atsuko, Tanaka Yoshiaki, Inoue Tomoyoshi, Yamane Keiko, Kubota Kousuke, Nakazawa Takahide, Shibuya Akitaka, Tanaka Yasuhito, Koizumi Wasaburo
Abstract excerpt
There have been few studies on relapse after a sustained virological response in hepatitis C virus (HCV) patients treated with interferon-free regimens. Thus, the risk of late relapse in patients treated with interferon-free therapy remains unclear. A 67-year-old woman with HCV genotype 1b and liver cirrhosis received oral daclatasvir and asunaprevir. Combination therapy was stopped after 4 weeks because of an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.